Other and Unspecified Pancreas
| Primary Site | Histology | Staging Type | 
|---|---|---|
| C253-C254, C257-C259 | 8000-8576, 8940-8950, 8971, 8980-8981 | TNM 7 and Summary Stage | 
| C253-C254, C257-C259 | 8577-8939, 8951-8970, 8972-8979, 8982-9136, 9141-9582, 9700-9701 | Summary Stage only | 
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C253 Pancreatic duct C254 Islets of Langerhans C257 Other specified parts of pancreas C258 Overlapping lesion of pancreas C259 Pancreas, NOS **Note 1:** This schema is based on the UICC chapter *Pancreas,* pages 132-135. * Primary sites C257, C258 and C259 are not listed in this chapter of the UICC manual; however, they are included in this schema and TNM staged if appropriate histology criteria are met **Note 2:** For tumors of the islet cells, determine which subsite of the pancreas is involved and use that primary site code and the corresponding schema. * If the subsite cannot be determined, use the general code for Islets of Langerhans, C254, and use the schema for Pancreas, Other and Unspecified **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Pancreas: Other and Unspecified* chapter on page 120 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=120).Main Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata | 
|---|---|---|---|---|---|
| Clinical T | Yes | NAACCR #940 tnmClinT | None | ||
| Clinical N | Yes | NAACCR #950 tnmClinN | None | ||
| Clinical M | Yes | NAACCR #960 tnmClinM | None | ||
| TNM Clin Stage Group | 99 | Yes | NAACCR #970 tnmClinStageGroup | None | |
| Pathologic T | Yes | NAACCR #880 tnmPathT | None | ||
| Pathologic N | Yes | NAACCR #890 tnmPathN | None | ||
| Pathologic M | Yes | NAACCR #900 tnmPathM | None | ||
| TNM Path Stage Group | 99 | Yes | NAACCR #910 tnmPathStageGroup | None | |
| SSF1: Carbohydrate Antigen 19-9 (CA 19-9) Lab Value | 988 | No | NAACCR #2880 csSiteSpecificFactor1 | None | None | 
| SSF2: Serum Chromogranin A (CgA) Lab Value | 988 | No | NAACCR #2890 csSiteSpecificFactor2 | None | None | 
| SSF3: Mitotic Count | 988 | No | NAACCR #2900 csSiteSpecificFactor3 | None | None | 
Additional Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata | 
|---|---|---|---|---|---|
| Year of Diagnosis | No | NAACCR #390 dateOfDiagnosis | None | ||
| Primary Site | Yes | NAACCR #400 primarySite | None | ||
| Histology | Yes | NAACCR #522 histologicTypeIcdO3 | None | ||
| Behavior | Yes | NAACCR #523 behaviorCodeIcdO3 | None | ||
| RX Summ Systemic/Surgery Sequence | Yes | NAACCR #1639 rxSummSystemicSurSeq | None | ||
| RX Summ Surgery/Radiation Sequence | Yes | NAACCR #1380 rxSummSurgRadSeq | None | ||
| Regional Nodes Positive | Yes | NAACCR #820 regionalNodesPositive | None | 
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata | 
|---|---|---|---|---|
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived SEER Clin Stage Group | 88 | NAACCR #3610 derivedSeerClinStgGrp | None | |
| Derived SEER Path Stage Group | 88 | NAACCR #3605 derivedSeerPathStgGrp | None | |
| Derived SEER Combined Stage Group | 88 | NAACCR #3614 derivedSeerCmbStgGrp | None | |
| Derived SEER Combined T | 88 | NAACCR #3616 derivedSeerCombinedT | None | |
| Derived SEER Combined N | 88 | NAACCR #3618 derivedSeerCombinedN | None | |
| Derived SEER Combined M | 88 | NAACCR #3620 derivedSeerCombinedM | None | |
| Derived SEER Combined T Source | <BLANK> | NAACCR #3622 derivedSeerCmbTSrc | None | |
| Derived SEER Combined N Source | <BLANK> | NAACCR #3624 derivedSeerCmbNSrc | None | |
| Derived SEER Combined M Source | <BLANK> | NAACCR #3626 derivedSeerCmbMSrc | None |